Despite having no training whatsoever in genetics, biology or psychology, Shockley devoted the last decades of his life to a quixotic struggle to prove that black Americans were suffering from ...

ACDN-01 is under clinical development by Ascidian Therapeutics and currently in Phase II for Retinopathy. According to GlobalData, Phase II drugs for Retinopathy have a 51% phase transition success ...

Once united, we must make collective decisions on the future direction of Kenya.” She emphasised: “We reject neo-colonialism, US-backed puppet leadership, and retrogressive policies in sectors like ...